ABSTRACT
Studies on the prevalence of infection by Dirofilaria immitis in Australian cats are rare. The current study aimed to determine the prevalence of infection with D. immitis in a tropical region of Australia by antigen, antibody and PCR testing. 172 healthy cats over 6 months of age from the Townsville region of Australia were tested for D. immitis specific antibodies and antigen using a commercially available kit. 50 samples were subsequently retested using a second commercially available antibody kit. 48 of these samples were checked for D. immitis DNA using PCR. No cat tested positive on any test. Maximum antigen and antibody prevalence was calculated as 1.27% and 2.10%, respectively.
Subject(s)
Cat Diseases , Dirofilaria immitis , Dirofilariasis , Animals , Antigens, Helminth , Australia/epidemiology , Cat Diseases/epidemiology , Cats , Dirofilaria immitis/genetics , Dirofilariasis/epidemiology , PrevalenceABSTRACT
Hyperammonaemia is well reported in animals with advanced hepatic disease and portosystemic shunts, but is unreported in cats with renal disease. This case series describes four cats with severe renal azotaemia in which elevated ammonia levels were detected during the course of treatment. In two cases hyperammonaemia was detected at a time when neurological signs consistent with encephalopathy had developed. This raises the possibility that hyperammonaemia may play a role in the development of encephalopathy in cats with renal azotaemia.
Subject(s)
Azotemia/veterinary , Cat Diseases/diagnosis , Cat Diseases/therapy , Hyperammonemia/veterinary , Animals , Azotemia/etiology , Azotemia/pathology , Cats , Hyperammonemia/therapy , Kidney Failure, Chronic/pathology , Kidney Failure, Chronic/veterinary , Portal System/abnormalitiesABSTRACT
Metaphyseal osteopathy, otherwise known as hypertrophic osteodystrophy, is a disease that causes pyrexia and lethargy accompanied by pain in the thoracic and pelvic limbs of rapidly growing large-breed dogs. While metaphyseal osteopathy has been descibed in association with slipped capital femoral epiphysis in cats, it has not previously been reported as a cause of limb pain and pyrexia in this species. A 7-month-old British Shorthair cat presented with a 1 month history of pyrexia, lethargy and pain in all limbs. Investigation included radiographs of the limbs and chest, abdominal ultrasound, serum biochemical analysis, haematology, bone biopsy, joint fluid aspiration and cytology. Findings were consistent with a diagnosis of metaphyseal osteopathy. The cat's clinical signs resolved following the administration of prednisolone. Symptoms recurred 1 month after the cessation of prednisolone therapy, but resolved when administration was resumed.
Subject(s)
Bone Diseases, Developmental/veterinary , Cat Diseases/diagnosis , Cat Diseases/drug therapy , Lameness, Animal/drug therapy , Animals , Anti-Inflammatory Agents/therapeutic use , Cat Diseases/pathology , Cats , Hypertrophy/veterinary , Lameness, Animal/etiology , Prednisolone/therapeutic use , Treatment OutcomeABSTRACT
Phaeochromocytomas are catecholamine-secreting tumours of the adrenal glands and are rare in cats. Plasma metanephrine levels are widely considered the diagnostic test of choice for phaeochromocytoma in people but have not been investigated in cats. In this study plasma free normetanephrine and metanephrine levels were measured using high-pressure liquid chromatography in healthy cats, sick cats with non-adrenal disease and in a cat with a suspected phaeochromocytoma. Plasma normetanephrine was significantly higher in sick cats with non-adrenal disease compared to healthy cats (P<0.05) and markedly higher in the cat with a suspected phaeochromocytoma when compared to either group. Plasma metanephrine was not significantly different in any of the groups. This study establishes a first-line guide reference range for plasma metanephrine and normetanephrine levels in healthy cats and cats with non-adrenal disease. These results provide rationale for further studies to establish the use of plasma normetanephrine levels as a potential diagnostic test for phaeochromocytoma in the cat.